Tiny Val­lon’s at­tempt at break­ing in­to the big Adder­all mar­ket just went up in smoke — and so did its stock

Last month, Val­lon Phar­ma­ceu­ti­cals tout­ed the hope that it could tap in­to the Adder­all mar­ket with an AD­HD med that de­ters peo­ple from drug abuse …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.